Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Infectious Disease
•
Non-Tuberculous Mycobacteria
•
Hospital Medicine
Do you recommend prescribing one or two parenteral antibiotics in addition to oral therapy in the management of Mycobacterium abscesses peritonitis related to peritoneal dialysis?
Related Questions
What is your preferred dosing of IV ganciclovir for CMV disease in immunocompromised patients?
What alternative treatment regimen do you recommend for patients with Mycobacterium kansasii lung infection who can no longer tolerate ethambutol due to drug toxicities?
How do you decide between ceftolozane/tazobactam and ceftazidime/avibactam for empiric treatment of an infection due to difficult-to-treat Pseudomonas aeruginosa while awaiting additional susceptibilities?
Do you prolong IV therapy or reduce the number of antibiotic agents for patients with pulmonary NTM infections who have completed induction IV therapy and cannot access oral antibiotic therapy due to cost?
Do you ever favor cefazolin over ceftriaxone for bacteremia with susceptible E. coli?
How do you manage recurrent C diff which occurs shortly after FMT when alternate etiologies of diarrhea have been excluded and patient is responding to C diff-directed therapies?
What would be an ideal time to place a VP shunt in a patient with candida meningitis/ventriculitis?
Under what circumstances do you consider valacyclovir for the management of VZV disease of the CNS?
Do you consider use of convalescent plasma early in disease course in COVID-19 induced ARDS in mechanically ventilated patients?
What are your top takeaways from ID Week 2024?
